2don MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...
Opinion
Worcester Telegram on MSNOpinion
Opinion/Guest column: New tech now closes in faster on cancer
We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
A path has now opened for early prostate cancer diagnosis through urine odor. Professor Koo Kyo-cheol of the Department of ...
For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results